Ningbonxing Medical Electric Co (SHSE:601567) Current Deferred Revenue: ¥1,480 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:601567 Ningbo Sanxing Medical Electric Co Ltd SHSE:601567
70 GF Score
Price ¥14.28
GF Value ¥27.18
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Ningbonxing Medical Electric Co Current Deferred Revenue?

Ningbonxing Medical Electric Co SHSE:601567 -0.14% 70 Current Deferred Revenue is ¥1,480 Mil as of Jun. 2026. GuruFocus rates SHSE:601567 with a GF Score™ of 70/100 and a GF Value™ of ¥27.18 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Ningbonxing Medical Electric Co's current deferred revenue for the quarter that ended in Jun. 2026 was ¥1,480 Mil.

Ningbonxing Medical Electric Co Current Deferred Revenue Related Terms

Ningbonxing Medical Electric Co Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Ningbonxing Medical Electric Co's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ningbonxing Medical Electric Co Current Deferred Revenue Chart

Ningbonxing Medical Electric Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 172.17 324.27 1,382.73 1,568.17 1,572.03

Ningbonxing Medical Electric Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 748.32 1,169.12 1,572.03 1,210.68 1,480.03
SHSE:601567
70GF Score
Ningbo Sanxing Medical Electric Co Ltd SHSE:601567
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of ¥1,480 Mil mean?
Ningbonxing Medical Electric Co (SHSE:601567) has a Current Deferred Revenue of ¥1,480 Mil as of Jun. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Ningbonxing Medical Electric Co and its competitors.
Is Ningbonxing Medical Electric Co's Current Deferred Revenue too high?
Ningbonxing Medical Electric Co's current Current Deferred Revenue is ¥1,480 Mil. Overall, Ningbonxing Medical Electric Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ningbonxing Medical Electric Co's Current Deferred Revenue compare to VRT and BE?
Ningbonxing Medical Electric Co's Current Deferred Revenue of ¥1,480 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for an Industrial Products company?
A good Current Deferred Revenue depends on the Industrial Products industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Ningbonxing Medical Electric Co and its competitors. Ningbonxing Medical Electric Co's current Current Deferred Revenue is ¥1,480 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ningbonxing Medical Electric Co stock overvalued right now?
Based on GuruFocus' analysis, Ningbonxing Medical Electric Co (SHSE:601567) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥27.18, compared to a current price of ¥14.28 — trading 47.5% below its estimated fair value. The current Current Deferred Revenue is ¥1,480 Mil. Ningbonxing Medical Electric Co's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Ningbonxing Medical Electric Co (SHSE:601567), the current Current Deferred Revenue is ¥1,480 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ningbonxing Medical Electric Co (SHSE:601567) Overvalued in 2026?

Based on GuruFocus' analysis, Ningbonxing Medical Electric Co stock appears to be undervalued. The current stock price of ¥14.28 is trading 47.5% below its estimated GF Value™ of ¥27.18. GuruFocus considers Ningbonxing Medical Electric Co to be Significantly Undervalued.

Key valuation signals for SHSE:601567:

  • Current Deferred Revenue: ¥1,480 Mil
  • GF Value™: ¥27.18 vs. price of ¥14.28 (47.5% below fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the SHSE:601567 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ningbonxing Medical Electric Co Business Description

Address Yinzhou Industrial Park, Jiangshan Town, Yinzhou District, Zhejiang Province, Ningbo, CHN, 315191
Ningbo Sanxing Medical Electric Co Ltd operates in the electricity measurement industry. The product portfolio of the group includes the Meter box, Smart substation, Switchgear, Power distribution automation devices, and others. The company also operates in the Medical Service segment, which is mainly engaged in the construction, operation, investment, and acquisition of hospitals, as well as the finance leasing of hospitals, among others. It generates the majority of its revenue from the Intelligent power distribution segment.
70GF Score

Get the complete analysis for SHSE:601567

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥14.28
Price
¥27.18
GF Value